The United Kingdom's COVID-19 vaccination program is an ongoing mass immunisation campaign that began on December 8, 2020, when Margaret Keenan became the first person in the world outside a clinical trial to receive a dose of the Pfizer-BioNTech vaccine. Regulated by the Medicines and Healthcare products Regulatory Agency, the program primarily used the Pfizer-BioNTech, Oxford-AstraZeneca and Moderna vaccines, delivered through a phased priority order starting with care home residents, health workers and the elderly. As recorded in the article's infobox, more than 53.7 million people had received at least one dose, more than 50.4 million had completed a two-dose course, and more than 40.1 million and 6.2 million had received third and fourth doses respectively.
Facts
Health Goalimmunisation of the public in the United Kingdom against COVID-19 1 Geographic Scope Measured Results92.9 percent of the population aged 12 and over received one dose, 86.8 percent received two doses, 69 percent received three doses 1 Program status (class) Classification
Program KindVaccination or Immunization Program 1 In the Other Atlases
- Also in Geography Atlas: Europe, found in there.
Sources
1. COVID-19 vaccination in the United Kingdom, Wikipedia
Infobox, Date field
Date: 8 December 2020 - present
Infobox, Cause field
Immunisation of the public in the United Kingdom against COVID-19
Infobox, Outcome field
92.9% of population 12+ received one dose; 86.8% received two doses; 69% received three doses
Infobox, Location field
Location: United Kingdom
- Wikipedia 'COVID-19 vaccination in the United Kingdom': explicitly 'is an ongoing mass immunisation campaign'; checked 2026-09-27.
Program classification, entity description sentence
The United Kingdom's COVID-19 vaccination program is an ongoing mass immunisation campaign that began on December 8, 2020, when Margaret Keenan became the first person in the world outside a clinical trial to receive a dose of the Pfizer-BioNTech vaccine.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.